Clinical Trials Sponsored by Peel Halton Acquired Brain Injury Services
Total 1 results
-
Toronto Rehabilitation InstituteOntario Neurotrauma Foundation; Peel Halton Acquired Brain Injury ServicesUnknownDepression | Brain Injury | AnxietyCanada
Sponsors and Collaborators
- Damagen Genetic Diagnostic Center
- Don Cockcroft
- Bon Secours Pediatric Dental Associates
- Narhalsan primary care rehabilitation
- José Castro
- Junta de Andalucía - Consejería de Salud y Familias, Spain
- Crowley Carter Foundation
- Biotics, Inc.
- Fabian Rohner
- Shanghai IxCell Biotechnology Co., LTD
- Universität Tübingen
- Castleton University
- Department of Cardiology, Lausanne University Center Hospital, Lausanne, Switzerland
- Plymouth University Peninsula Schools of Medicine & Dentistry (PUPSMD)
- Hospital Sirio-Libanes Ensino e Pesquina
- GTEI
- University of Valladolid
- MB Clinical Research, LLC
- Belfast Arthroplasty Research Trust (BART)
- Mexican Emerging Infectious Diseases Clinical Research Network
- View Full List
Medical Conditions
- Lenses
- Cystic Fibrosis in Adults, Chronic Colonization With Pseudomonas Aeruginosa
- Adolescent Oncology Patients
- Milk Expression, Breast
- Vascular Aging
- Infarction, Myocardial
- Support Groups
- Lung Cancer Non Small Cell
- Nasotracheal Intubation
- Gallbladder and Bile Duct Calculi
- Congenital Nephrogenic Diabetes Insipidus
- Residual Curarization
- Stage V Wilms Tumor
- Syndrome Heart Disease
- Health Services, Geriatric
- Chronic Arthritis, Longer Than Six Weeks Duration
- Vesicoureteral Reflux (VUR)
- Cryptococcosis or Aspergillosis Infections
- Refractory Childhood Epilepsy
- PSA Level Greater Than or Equal to 0.5
- View Full List
Drug Interventions
- ABT-199
- Etanercept
- Quadratus Lumborum Block type 2
- Sulfasalazine
- Metoprolol succinate sustained-release tablet
- Fluorescein + ALA
- Granulocyte colony-stimulating factor (G-CSF)
- Lidocaine, epinephrine (Local anesthetic)
- PEP005 Gel
- SNAC
- Doxorubicin, L-asparaginase, PEG-L-asparaginase, Erwinia asparaginase
- PF-05212384
- Cabozantinib
- Dapagliflozin
- Fluorouracil
- Trimetazidine 35 mg
- Azacitidine
- Gliadel Wafer
- ATG-010 60 mg, orally, twice weekly, each 4 week (28-day) a cycle
- Axitinib plus toripalimab
- View Full List
CROs by country
- Contract Research Organizations in Belgium
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Ghana
- Contract Research Organizations in Iran
- Contract Research Organizations in Ireland
- Contract Research Organizations in Jamaica
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Morocco
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Thailand
- Contract Research Organizations in Zimbabwe
- CRO list by country